drugset / Trial / NCT04762719
PET Imaging to Delineate Macrophage Activation in Diabetic Gastroparesis
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
Macrophage-driven immune dysregulation has been shown to be involved in pathophysiology of diabetic gastroparesis. Currently, there are no non-invasive ways to study macrophage activation in humans. The researchers are trying to determine the utility of 11C-ER176 based PET-CT scanning to determine pro-inflammatory macrophage activation in gastric wall of patients with diabetic gastroparesis.
Timeline
- Start
- 2021-05-10
- Primary completion
- 2022-03-31
- Completion
- 2022-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 11C-ER176 | Diagnostic / imaging agent | 518 mbq | Intravenous |